These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4317029)

  • 61. [Pyrazinamide-containing initial intensive short course chemotherapy of pulmonary tuberculosis].
    Wada M
    Kekkaku; 1997 Oct; 72(10):587-95. PubMed ID: 9386358
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [New chemotherapeutic drugs for the treatment of pulmonary tuberculosis: neoniazid, nupasal, reazide, viomycin, terramycin, pyrazinamide and cycloserine].
    DOUMA J; MULDER RJ
    Ned Tijdschr Geneeskd; 1956 Jul; 100(29):2053-65. PubMed ID: 13369614
    [No Abstract]   [Full Text] [Related]  

  • 63. Clinical efficiency of cycloserine in association with other tuberculostatics.
    Anastasatu C; Ulpian C; Weiss P
    Scand J Respir Dis Suppl; 1970; 71():152-4. PubMed ID: 5271976
    [No Abstract]   [Full Text] [Related]  

  • 64. [Experimental studies on intermittent use of rifampicin alone or combined with other secondary antituberculous drugs].
    Suzuki T
    Kekkaku; 1971 May; 46(5):153-64. PubMed ID: 4325363
    [No Abstract]   [Full Text] [Related]  

  • 65. Treatment outcome of multidrug-resistant tuberculosis among Vietnamese immigrants.
    Ward HA; Marciniuk DD; Hoeppner VH; Jones W
    Int J Tuberc Lung Dis; 2005 Feb; 9(2):164-9. PubMed ID: 15732735
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Short course chemotherapy for pulmonary tuberculosis. 3. Initial intensive regimens including pyrazinamide].
    Suzuki T; Shimada M; Yamaguchi W; Kameda K; Okamura S; Aizawa H
    Kekkaku; 1983 Sep; 58(9):459-64. PubMed ID: 6663962
    [No Abstract]   [Full Text] [Related]  

  • 67. [Results of 2 or 3 secondary drug combinations in the retreatment of chronic pulmonary tuberculosis].
    De March Ayuela P; Turell Gumá J
    Rev Clin Esp; 1968 Apr; 109(2):117-26. PubMed ID: 4904020
    [No Abstract]   [Full Text] [Related]  

  • 68. [Tuberculostatic preparations of the 2d series in the clinical treatment of pulmonary tuberculosis].
    Kaminskaia AA; Utkin VV; Korotaev GA; Golitsina LV
    Probl Tuberk; 1967; 45(5):29-33. PubMed ID: 5617941
    [No Abstract]   [Full Text] [Related]  

  • 69. Dosage schedules for tuberculosis patients.
    Jonker R
    S Afr Med J; 1987 Sep; 72(6):440. PubMed ID: 3660141
    [No Abstract]   [Full Text] [Related]  

  • 70. [2 complications of primary pulmonary tuberculosis in children].
    Abbo AW
    Ned Tijdschr Geneeskd; 1992 May; 136(21):1032. PubMed ID: 1603149
    [No Abstract]   [Full Text] [Related]  

  • 71. Pyrazinamide and ethionamide in the treatment of pulmonary tuberculosis in Hong Kong.
    Sister AQUINAS
    Tubercle; 1963 Mar; 44():76-81. PubMed ID: 14013505
    [No Abstract]   [Full Text] [Related]  

  • 72. Resectional therapy for pulmonary tuberculosis at Summount, 1950-1957; 807 cases. V. Resectional therapy for pulmonary tuberculosis under viomycin and pyrazinamide coverage.
    KIMEL VM
    Dis Chest; 1961 Mar; 39():249-50. PubMed ID: 13755996
    [No Abstract]   [Full Text] [Related]  

  • 73. [Toxic reactions during treatment with viomycin in pulmonary tuberculosis].
    Radecki A; Kanwiszer H; Donderowicz A; Krzanowska E
    Gruzlica; 1968 Apr; 36(4):323-7. PubMed ID: 4300342
    [No Abstract]   [Full Text] [Related]  

  • 74. Absorption, metabolism and excretion of pyrazinamide in man.
    Ellard GA
    Tubercle; 1969 Jun; 50(2):144-58. PubMed ID: 5788407
    [No Abstract]   [Full Text] [Related]  

  • 75. [Contribution to the study of intravenous viocin used alone in heroic treatment of pulmonary tuberculosis].
    Masselot I; Meslier de Rocan J
    Rev Tuberc Pneumol (Paris); 1965 Apr; 29(4):353-63. PubMed ID: 4284231
    [No Abstract]   [Full Text] [Related]  

  • 76. [The effect of D-cycloserin and florimycin on the activity of glutamate aspartate transaminase in blood serum of albino mice].
    Krepak OM
    Antibiotiki; 1966 Apr; 11(4):347-50. PubMed ID: 4293568
    [No Abstract]   [Full Text] [Related]  

  • 77. [The course and results of treatment of pulmonary tuberculosis as a function of the dosage of Pyrazinamide].
    Malinowska B; Pawlak F
    Gruzlica; 1970; 38(6):531-5. PubMed ID: 4317029
    [No Abstract]   [Full Text] [Related]  

  • 78. [Treatment of drug resistant chronic pulmonary tuberculosis with a number of tuberculostatics].
    Bernard E
    Bull Int Union Tuberc; 1968 Dec; 41():183-7. PubMed ID: 4303862
    [No Abstract]   [Full Text] [Related]  

  • 79. A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.
    Bignall JR
    Bull Int Union Tuberc; 1968 Dec; 41():175-7. PubMed ID: 4885379
    [No Abstract]   [Full Text] [Related]  

  • 80. Treatment of patients with drug-resistance in economically developed countries.
    Crofton J
    Tubercle; 1969 Mar; 50():Suppl:65-8. PubMed ID: 4319134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.